Efficacy of Dexmedetomidine VS Magnesium Sulphate With Bupivacaine in Erector Spinae Block for Thoracotomy Pain
NCT ID: NCT05851768
Last Updated: 2024-02-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
60 participants
INTERVENTIONAL
2023-05-15
2024-04-27
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Dexmedetomidine vs Dexamethasone as Adjuvant to Bupivacaine in Bilevel Erector Spinae Plane Block in Breast Surgeries
NCT05591417
Erector Spinae Block Using a Dexmedetomidine Versus Magnesium Sulfate as an Adjuvant to Bupivacaine
NCT05694897
Effect of Adding Dexmedetomidine As Adjuvant to Bupivacaine in US Guided ESPB for Post MRM Pain Management
NCT06022614
Dexamethasone Versus Mg Added to Bupivacaine Used in ESPB for Perioperative Pain Control in Patients Undergoing Unilateral Nephrectomy
NCT06501079
Bupivicain vs Bupivicain Plus Dexamethasone in ESP Block for Post-op Analgesia
NCT05277974
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Erector spinae plane block with 0.25% bupivacaine
Patients will receive ultrasound guided ESPB with 0.25% bupivacaine
Bupivacaine
Bupivacaine 0.25%
Erector spinae plane block with 0.25% bupivacaine and Magnesium
Patients will receive ultrasound guided ESPB with 0.25% bupivacaine and magnesium
Bupivacaine + Magnesium
Bupivacaine 0.25% + Magnesium
Erector spinae plane block with 0.25% bupivacaine and Dexmedetomidine
Patients will receive ultrasound guided ESPB with 0.25% bupivacaine and dexmedetomidine
Bupivacaine + Dexmedetomidine
Bupivacaine 0.25% + Dexmedetomidine
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Bupivacaine
Bupivacaine 0.25%
Bupivacaine + Magnesium
Bupivacaine 0.25% + Magnesium
Bupivacaine + Dexmedetomidine
Bupivacaine 0.25% + Dexmedetomidine
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Male and female sexes.
* ASA I-II.,III
* Cancer patients undergoing thoracotomy incisions
* Body mass index (BMI) from 18.5 to 30 kg/m2
Exclusion Criteria
* Known allergy to any of the used drugs
* Low platelet count, any coagulation defect
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Cancer Institute, Egypt
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Walaa Youssef Elsabeeny
Assistant professor of Anesthesia and Pain management
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Walaa Y Elsabeeny, MD
Role: PRINCIPAL_INVESTIGATOR
Assistant professor of Anesthesia and Pain Management, National Cancer Institute, Cairo University
Ahmed A Mohamed, MD
Role: STUDY_DIRECTOR
Professor of Anesthesia,Surgical intensive care and Pain management,Faculty of medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Walaa Y Elsabeeny
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
N-80-2022/NSC
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.